Evidence map›Paper›PMID 38048011›Full record

ArticleJournal of cancer survivorship : research and practice2025

European recommendations for short-term surveillance of health problems in childhood, adolescent and young adult cancer survivors from the end of treatment to 5 years after diagnosis: a PanCare guideline.

Ismay A E de Beijer, Roderick Skinner, Riccardo Haupt, Desiree Grabow, Edit Bardi, Andrea Beccaria, Adela Cañete Nieto, Samira Essiaf, Anna-Liesa Filbert, Hannah Gsell and 12 more

Abstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ismay A E de BeijerPrincess Maxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. i.a.e.debeijer-3@prinsesmaximacentrum.nl.
Roderick SkinnerWolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Herschel Building, Brewery Lane, Newcastle Upon Tyne, NE1 7RU, UK.
Riccardo HauptIRCCS Istituto Giannina Gaslini, Genoa, Italy.
Desiree GrabowDivision of Childhood Cancer Epidemiology/German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
Edit BardiSt. Anna Children's Hospital, Vienna, Austria.
Andrea BeccariaIRCCS Istituto Giannina Gaslini, Genoa, Italy.
Adela Cañete NietoHospital Universitario y Politécnico La Fe, Valencia, Spain.
Samira EssiafEuropean Society for Paediatric Oncology, C/O BLSI, Clos Chapelle-Aux-Champs 30, Bte 1.30.30, Brussels, Belgium.
Anna-Liesa FilbertDivision of Childhood Cancer Epidemiology/German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
Hannah GsellCCI Europe, Vienna, Austria.
Anita KienesbergerCCI Europe, Vienna, Austria.
Thorsten LangerUniversitatsklinikum Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.
Patricia McColganChildhood Cancer Ireland, Carmichael House, 4 Brunswick Street North, Dublin, D07 RHA8, Ireland.
Monica MuracaIRCCS Istituto Giannina Gaslini, Genoa, Italy.
Jelena RasconVilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Ramona TalloneIRCCS Istituto Giannina Gaslini, Genoa, Italy.
Zuzana TomasikovaCCI Europe, Vienna, Austria.
Anne UyttebroeckUniversity Hospitals Leuven, KU Leuven, Louvain, Belgium.
Leontien C M KremerPrincess Maxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Helena J H van der Pal *Princess Maxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Renée L Mulder *Princess Maxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
PanCareSurPass consortium

Funding

Horizon 2020 899999
6 · The paper itself

Abstract

purposeChildhood, adolescent and young adult (CAYA) cancer survivors require ongoing surveillance for health problems from the end of cancer treatment throughout their lives. There is a lack of evidence-based guidelines on optimal surveillance strategies for the period from the end of treatment to 5 years after diagnosis. We aimed to address this gap by developing recommendations for short-term surveillance of health problems based on existing long-term follow-up (LTFU) care guidelines.

methodsThe guideline working group, consisting of healthcare professionals, parents and survivor representatives from 10 countries, worked together to identify relevant health problems that may occur in survivors between the end of treatment and 5 years after diagnosis and to develop recommendations for short-term surveillance of health problems. The recommendations were drawn from existing LTFU guidelines and adapted where necessary based on clinical expertise.

resultsThe working group developed 44 recommendations for short-term surveillance of health problems, which were divided into four categories based on the level of surveillance required: awareness only (n = 11), awareness, history and/or physical examination without surveillance test (n = 15), awareness, history and/or physical examination with potential surveillance test (n = 1) and awareness, history and/or physical examination with surveillance test (n = 17).

conclusionThe development of a guideline for short-term surveillance of health problems fills a critical gap in survivorship care for CAYA cancer survivors, providing much-needed support immediately after treatment up to 5 years after diagnosis. IMPLICATIONS FOR CANCER SURVIVORS: This guideline will support healthcare professionals to provide appropriate follow-up care and improve the quality of life of CAYA cancer survivors.

Indexed as

Cancer SurvivorsNeoplasmsPractice Guidelines as TopicAdolescentAdultChildEuropeFemaleHumansMalePopulation SurveillanceSurvivorshipYoung AdultAftercareCancer survivorsPaediatric oncologyPractice guidelineQuality of lifeShort-term follow-up careSurveillanceSurvivorshipSurvivorship Passport

Identifiers

PMID38048011
PMCPMC11925970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.